Sentence examples for for the ongoing trials from inspiring English sources

The same can be said for the ongoing trials of soldiers allegedly responsible for a massacre in North Jakarta 20 years ago.One thing that is fairly certain is that the issue will excite more interest abroad than in Indonesia especially in Australia, which lost more of its nationals than any other country in the Bali bombing.

We will search the metaRegister of Controlled Trials (mRCT; http://www.controlled-trials.com/mrct), Clinical trials.gov (http://www.clinicaltrials.gov) and the WHO International Clinical Trials Registry platform (ICTRP) (http://apps.who.int/trialsearch/) for the ongoing trials.

However, most of the ongoing trials for lung cancer at the CTONG are observational phase 2 and 3 studies [ 10].

Response times (RTs) for correct responses and accuracy of the ongoing trials (i.e., all trials of the OG condition and those of PM blocks that were not associated with a PM response) were analyzed separately for stay, switch, and nonswitch trials.

The courts have little independence on politically sensitive cases and the misuse of the anti-terrorism law is illustrated through the ongoing trial of an opposition leader and advocate for non-violence, Bekele Gerba, the ongoing trial of a former World Bank translator, Pastor Omot Agwa, and the conviction of numerous journalists on trumped-up charges.

This paper describes the protocol for this ongoing trial.

The preferred dose and schedule for tremelimumab for ongoing trials has generally been 10 mg/kg intravenously, every 4 weeks for 6 months.

Literature searches were conducted in MEDLINE (1966-August 2007), EMBASE (1988-August 2007), the Cochrane library (including DARE and CENTRAL), the British Library Allied and Complementary Medicines database (AMED 1985-August 2007) and the National Research Register for ongoing trials.

Both reviewers also independently searched the websites for ongoing trials.

Subsequent studies established that olaparib, a potent PARP inhibitor, yielded notable clinical activity in BRCA mutation carriers with breast and ovarian cancers (Fong et al, 2009), providing the basis for ongoing trials (Moore et al, 2014).

The design and protocol for the ongoing BBII trial is described.